Cas:82499-43-2 bicyclo[2.2.1]hepta-2,5-diene,4-diphenylphosphanylbutyl(diphenyl)phosphane,rhodium,tetrafluoroborate manufacturer & supplier

We serve Chemical Name:bicyclo[2.2.1]hepta-2,5-diene,4-diphenylphosphanylbutyl(diphenyl)phosphane,rhodium,tetrafluoroborate CAS:82499-43-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

bicyclo[2.2.1]hepta-2,5-diene,4-diphenylphosphanylbutyl(diphenyl)phosphane,rhodium,tetrafluoroborate

Chemical Name:bicyclo[2.2.1]hepta-2,5-diene,4-diphenylphosphanylbutyl(diphenyl)phosphane,rhodium,tetrafluoroborate
CAS.NO:82499-43-2
Synonyms:MFCD00075218
Molecular Formula:C38H42BF4OP2Rh
Molecular Weight:766.39700
HS Code:

Physical and Chemical Properties:
Melting point:210ºC (dec.)(lit.)
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:44.25000
Exact Mass:766.18000
LogP:9.67620

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like MFCD00075218 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00075218 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00075218 Use and application,MFCD00075218 technical grade,usp/ep/jp grade.


Related News: In recent years, it has benefited significantly from the development of a broad range of enabling technologies, leading biocatalysis to become an established methodology for efficient, sustainable manufacturing, especially within the drug development industry. Synthetase, acetyl coenzyme A (Penicillium chrysogenum strainDAOM-216700 gene acuA fragment) manufacturers The inhaled two-dose candidate is modified from CanSinoBIO’s injected COVID-19 jab Ad5-nCoV vaccine, which is already approved in China and other countries around the world. 4-(3-(furan-2-yl)-5-methyl-2-oxo-2,5-dihydro-1H-pyrido[3,2-b]indol-1-yl)benzonitrile suppliers The plant will complement Recipharm’s existing sites in France, Germany and Italy and will be focused on securing approvals from regulators in Europe and the U.S. ethyl (E)-3-(4-(3-((4,5-dihydro-1H-imidazol-2-yl)amino)benzamido)-3,5-dimethylphenyl)acrylate vendor & factory.